Hydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium

Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2871. doi: 10.1007/s00417-020-04727-3. Epub 2020 May 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents / toxicity
  • Antiviral Agents / toxicity*
  • Betacoronavirus / drug effects*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Cytochrome P-450 CYP3A Inhibitors / toxicity
  • Drug Synergism
  • Humans
  • Hydroxychloroquine / toxicity*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Retinal Diseases / chemically induced*
  • Retinal Pigment Epithelium / drug effects*
  • Ritonavir / toxicity*
  • SARS-CoV-2

Substances

  • Antirheumatic Agents
  • Antiviral Agents
  • Cytochrome P-450 CYP3A Inhibitors
  • Hydroxychloroquine
  • Ritonavir